Fig. 6From: A mathematical modelling tool for unravelling the antibody-mediated effects on CTLA-4 interactionsThe simulation of full dose-response curves for the two antibodies, ipilimumab (a) and tremelimumab (b) in the free-diffusion model. The % increase in the CD28/B7 complex during the full-dose response simulations with ipilimumab and tremelimumab are also plotted (c)Back to article page